Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
Songyan YuYu ChengLinxi ZhangYaqi YinJing XueBing LiZhengyuan GongJieqing GaoYi-Ming MuPublished in: Stem cell research & therapy (2019)
Multiple intravenous infusions of ADSCs produced significant protective effects against long-term T2DM complications by alleviating inflammation and promoting tissue repair. The present study suggests ADSCs may be a novel, alternative cell therapy for long-term diabetic complications.